Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Abbott India Ltd. Regulatory Filings 2021

Jun 28, 2021

61121_rns_2021-06-28_bf2dfbc5-c96c-41bc-8e3d-37586428d78a.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [104 x 103] intentionally omitted <==

Abbott India Limited Registered Office: Tel: (91-22) 5046 1000/2000 Godrej BKC, Plot C-68,”G”Block, 3, Corporate Park, Fax : (91-22) 5016 9400 15-16th Floor, Bandra-Kurla Complex, Sion-Trombay Road, E-mail : [email protected] Near MCA Club, Bandra (E), Mumbai - 400 071.India Website : www.abbott.co.in Mumbai - 400 051. India CIN: L24239MH1944PLC007330

To,

June 28, 2021

BSE Limited Department of Corporate Services Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400 001

Scrip Code No. 500488

Subject: Disclosure under Regulation 46 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Outcome of Institutional Shareholders/Analysts Meet

Dear Sirs,

With reference to our earlier letter dated June 24, 2021 regarding the Institutional Shareholders/Analysts Meet, please note that the complete recording of the Meeting is available on the website of the Company at www.abbott.co.in. Further, the transcript of the same shall be uploaded on the website of the Company in due course.

This for your information and records.

Thanking you,

Yours sincerely,

Abbott India Limited

==> picture [59 x 55] intentionally omitted <==

Krupa Anandpara Company Secretary Membership No.: ACS 16536